Multiple Sclerosis
Conference Coverage
How to Treat Pediatric MS
VANCOUVER—Pediatric multiple sclerosis (MS) presents unique concerns, making appropriate treatment especially important, according to an overview...
Literature Review
Switch From Fingolimod to Alemtuzumab Might Trigger MS Relapse
Nine patients with relapsing multiple sclerosis had significant and unexpected disease activity within 12 months of switching from fingolimod to...
Literature Review
Relatives of Patients With MS Show Early Signs of Disease
Asymptomatic first-degree relatives of patients with multiple sclerosis (MS) who are at high risk for developing the disease are significantly...
Feature
Humira Pen topped per-person drug spending in 2016
The spending top 10 includes three drugs for diabetes, two for arthritis/psoriasis, and two for multiple sclerosis.
Literature Review
Ocrelizumab Reduces Disease Progression in MS
Ocrelizumab is associated with lower rates of disease activity and progression in patients with relapsing-remitting multiple sclerosis (MS),...
Literature Review
Treatment Reduces Risk of Long-Term Disability in MS
Compared with the natural history of the disease, disease-modifying treatments for multiple sclerosis (MS) significantly reduce the risks of long-...
Feature
New report highlights gaps in knowledge on marijuana use
Evidence review shows when using cannabis or cannabinoids is effective, ineffective, or harmful.
From the Journals
Switch from fingolimod to alemtuzumab might trigger MS relapse
Nine relapsing multiple sclerosis patients had significant and unexpected disease activity within 12 months of switching from fingolimod to...
From the Journals
High-risk relatives of MS patients show early signs of disease
Asymptomatic first-degree relatives of multiple sclerosis patients at high risk for developing the disease were significantly more likely to show...
Conference Coverage
Rituximab May Have Advantages Over Fingolimod and Natalizumab in MS
LONDON—As a first- or second-line agent for relapsing-remitting multiple sclerosis (MS), rituximab demonstrates superior drug survival (ie, the...
Conference Coverage
What Are the Best Treatments for Bladder Dysfunction in MS?
LONDON—Many patients with multiple sclerosis (MS) suffer from bladder dysfunction, however, few of these patients have their symptoms managed,...